Steven A Rosenberg

USPTO Granted Patents = 139 (Patent Applications = 59)

CIPO Patents = 21 (Patent Applications = 38)

EPO Patents = 44 (Patent Applications = 82)

Average Co-Inventor Count = 2.7

ph-index = 26

Forward Citations = 3,333(Granted Patents)

Forward Citations (Not Self Cited) = 3,032(Dec 10, 2025)

Inventors with similar research interests:

Location History:

South Plainfield, NJ (US) (1995 - 2012)
Bethesda, MD (US) (1987 - 2023)
Potomac, MD (US) (1998 - 2024)

Company Filing History:

118 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

12 out of 1,217

The United States of America As Represented by the Department of Health

patents

11 out of 2,308

University of Minnesota

patents

4. 11 out of 13

Intima Bioscience, Inc.

The United States of America As Represented by the Secretary of

patents

7. 1 out of 1,168

Yeda Research and Develpment & Co. Ltd

Therion Biologics Corporation

patents

10. 1 out of 28

The Government of the United States of America, As Represented by the

patents

11. 1 out of 13

The United States of America As Represented by the Secretary, Department

patents

12. 1 out of 33

Wilson Wolf Manufacturing Corporation

patents

13. 4 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1987-2025

Loading Chart...

Areas of Expertise:

T Cell Therapy

Hla Class Ii

T Cell Receptors

Cancer-Specific Mutations

Intracellular Genomic Transplant

Tumor Infiltrating Lymphocytes

Chimeric Antigen Receptors

Anti-Human Papillomavirus

Kras Mutations

Dendritic Cells

Neoantigen-Specific T Cells

Memory T Cells

139 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458654 - Methods of conditioning patients for T cell therapy (2025-11-04),

2. 12448428 - HLA class II-restricted t cell receptors against RAS with G12R mutation (2025-10-21),

3. 12441778 - T cell receptors recognizing HLA-A1-restricted MAGE-A3 (2025-10-14),

4. 12404317 - T cell receptors recognizing MHC class II-restricted MAGE-A3 (2025-09-02),

5. 12391742 - Anti-KRAS-G12D T cell receptors (2025-08-19),

6. 12304940 - HLA class II-restricted t cell receptors against mutated RAS (2025-05-20),

7. 12227554 - Methods for selectively expanding cells expressing a TCR with a murine constant region (2025-02-18),

8. 12221627 - Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cells (2025-02-11),

9. 12187779 - Anti-human papillomavirus 16 E6 T cell receptors (2025-01-07),

10. 12171818 - Methods of isolating T cells having antigenic specificity for a cancer-specific mutation (2024-12-24),

11. 11976299 - Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same (2024-05-07),

12. 11939365 - T cell receptors recognizing mutated P53 (2024-03-26),

13. 11925664 - Intracellular genomic transplant and methods of therapy (2024-03-12),

14. 11918640 - Methods of preparing anti-human papillomavirus antigen T cells (2024-03-05),

15. 11903966 - Intracellular genomic transplant and methods of therapy (2024-02-20),

Title: The Innovative Journey of Steven A. Rosenberg

Introduction: Steven A. Rosenberg, a distinguished inventor based in Potomac, MD (US), has made significant contributions to the field of innovation through his groundbreaking work in various patents.

Latest Patents: Steven A. Rosenberg holds several patents in the areas of medical devices and biotechnology, focusing on advancements in cancer treatment and personalized medicine.

Career Highlights: With a career spanning over three decades, Steven A. Rosenberg has established himself as a leading figure in the world of inventors. His innovative solutions have revolutionized the way we approach healthcare and have led to improved patient outcomes.

Collaborations: Throughout his career, Steven A. Rosenberg has collaborated with top research institutions, universities, and medical professionals to further his inventions and bring them to market. His collaborative spirit has been instrumental in the success of his patented technologies.

Conclusion: Steven A. Rosenberg's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His work continues to inspire future generations of inventors to push the boundaries of what is possible in the world of patents and inventions.

This text is generated by artificial intelligence and may not be accurate.